John Patrick Darby Sells 14,543 Shares of Encompass Health Co. (NYSE:EHC) Stock

Encompass Health Co. (NYSE:EHC) EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the completion of the transaction, the executive vice president now owns 84,773 shares in the company, valued at $7,115,845.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Encompass Health Trading Down 0.7 %

Shares of NYSE:EHC opened at $85.32 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14. The company has a market capitalization of $8.59 billion, a PE ratio of 23.18, a P/E/G ratio of 1.30 and a beta of 0.92. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $86.60. The business’s fifty day simple moving average is $79.54 and its 200-day simple moving average is $71.95.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the firm earned $0.88 earnings per share. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. As a group, equities research analysts predict that Encompass Health Co. will post 4.1 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be paid a $0.15 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.60 annualized dividend and a yield of 0.70%. Encompass Health’s dividend payout ratio (DPR) is 16.22%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on EHC. Truist Financial upped their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Barclays raised their price objective on Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, April 25th. Stephens reiterated an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Raymond James restated a “strong-buy” rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a research note on Friday, April 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a research note on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $90.29.

Hedge Funds Weigh In On Encompass Health

Several institutional investors and hedge funds have recently bought and sold shares of the company. TD Asset Management Inc boosted its position in shares of Encompass Health by 16.0% in the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock worth $188,586,000 after purchasing an additional 314,488 shares in the last quarter. Entropy Technologies LP boosted its holdings in Encompass Health by 32.5% in the first quarter. Entropy Technologies LP now owns 11,398 shares of the company’s stock worth $941,000 after acquiring an additional 2,798 shares in the last quarter. QRG Capital Management Inc. grew its stake in shares of Encompass Health by 23.4% during the first quarter. QRG Capital Management Inc. now owns 7,738 shares of the company’s stock worth $639,000 after acquiring an additional 1,467 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of Encompass Health by 75.4% during the first quarter. Inspire Investing LLC now owns 34,470 shares of the company’s stock valued at $2,847,000 after acquiring an additional 14,818 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Encompass Health in the 1st quarter valued at approximately $816,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.